It's a time for CLOV.US - 70% potential profit - 4.70 USDClover Health Investments, Corp.BATS:CLOVdarksignalThe presented 4-hour chart of Clover Health (CLOV) shows a prolonged downtrend that has clearly begun to lose momentum in recent weeks. Price has stabilized in the 2.50–2.70 USD range, which can be interpreted as a base-building and accumulation phase after a strong bearish move. This zone has been defended multiple times, suggesting the presence of demand and a gradual exhaustion of selling pressure. Moving averages are starting to flatten, and on shorter swings the price structure is shifting from lower lows toward the formation of higher lows. This is often an early technical signal of a potential trend reversal or the beginning of a broader recovery phase. Price holding above the recent consolidation area further supports the bullish scenario. The RSI indicator is positioned in the neutral zone with a clear upward bias, recovering from previously oversold levels. This indicates improving bullish momentum and suggests there is still room for upside without the market being overextended. The absence of bearish divergences strengthens the case for continued upside movement. From a technical perspective, the first key upside target lies in the 3.30–3.50 USD resistance zone, where strong selling pressure was previously observed. A confirmed breakout and sustained price action above this level could trigger a stronger bullish impulse. In such a scenario, the next major target would be around 4.70 USD, derived from prior swing highs and the broader market structure, as well as common Fibonacci expansion levels. In summary, the chart suggests that CLOV may be transitioning from a bearish trend into a potential bullish phase. As long as price remains above the 2.50 USD support zone and successfully breaks through intermediate resistance levels, the probability of a move toward the 4.70 USD target increases over the medium term. Potential TP: 4.70 $ Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. Trading and investing in financial markets involve significant risk, and past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.